Follow-up of percutaneous microwave (MW) ablation of hepatic lesion: predictive value of CT at 24-h compared with CT at 1 month.
Adult
Aged
Aged, 80 and over
Carcinoma, Hepatocellular
/ diagnostic imaging
Catheter Ablation
Female
Follow-Up Studies
Humans
Liver
/ diagnostic imaging
Liver Neoplasms
/ diagnostic imaging
Male
Microwaves
/ therapeutic use
Middle Aged
Neoplasm, Residual
Retrospective Studies
Surgery, Computer-Assisted
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Ultrasonography
CT scan
Follow-up
Hepatocellular carcinoma
MW ablation
Surveillance
Journal
Medical oncology (Northwood, London, England)
ISSN: 1559-131X
Titre abrégé: Med Oncol
Pays: United States
ID NLM: 9435512
Informations de publication
Date de publication:
07 Apr 2020
07 Apr 2020
Historique:
received:
12
01
2020
accepted:
17
03
2020
entrez:
9
4
2020
pubmed:
9
4
2020
medline:
13
11
2020
Statut:
epublish
Résumé
To retrospectively assess the predictive value of the CT performed at 24 h, compared with the CT performed at 1 month, in the evaluation of the technical success of microwave (MW) ablation of hepatic lesions. In a single center, 50 patients with HCC underwent percutaneous MW ablation between November 2016 and March 2019. Each patient underwent a contrast-enhanced CT exam at 24 h and at 1 month after the procedure. For each patient, was assessed the presence or absence of residual disease, the appearance of a new lesion, complications, and the involvement of the hepatic capsule, both at 24-h and at 1 month. Overall correlation between residual disease, appearance of a new nodule and complications was also assessed. A total of 50 hepatic lesions were treated with US-guided MW ablation. Patients' mean age was 70.9 years (range 28-87 years). Mean nodule diameter was 17.6 mm (range 7-35 mm). Contingency tables and the χ
Identifiants
pubmed: 32266568
doi: 10.1007/s12032-020-01364-y
pii: 10.1007/s12032-020-01364-y
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
41Références
Can Assoc Radiol J. 2018 Feb;69(1):51-62
pubmed: 29458955
Dig Liver Dis. 2013 Sep;45(9):712-23
pubmed: 23769756
Clin Cancer Res. 2013 Mar 15;19(6):1312-4
pubmed: 23382112
World J Hepatol. 2015 Sep 18;7(20):2274-91
pubmed: 26380652
Cardiovasc Intervent Radiol. 2017 Aug;40(8):1141-1146
pubmed: 28584945
J Natl Compr Canc Netw. 2017 May;15(5):563-573
pubmed: 28476736
Am J Transplant. 2009 Aug;9(8):1920-8
pubmed: 19552767
J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S126-9
pubmed: 25755604
BMC Cancer. 2018 Nov 29;18(1):1186
pubmed: 30497418
World J Gastroenterol. 2013 Sep 7;19(33):5430-8
pubmed: 24023485
J Hepatol. 2010 Aug;53(2):291-7
pubmed: 20483497
J Hepatol. 2001 Sep;35(3):421-30
pubmed: 11592607
Hepatogastroenterology. 1998 Aug;45 Suppl 3:1214-20
pubmed: 9730377
Cardiovasc Intervent Radiol. 2010 Feb;33(1):11-7
pubmed: 19924474
J Vasc Interv Radiol. 2015 Jan;26(1):69-73
pubmed: 25446423
Hepatology. 1992 Jul;16(1):132-7
pubmed: 1352268
Semin Intervent Radiol. 2006 Mar;23(1):73-84
pubmed: 21326722
Can Urol Assoc J. 2018 Feb;12(2):59-66
pubmed: 29381453
Clin Radiol. 2017 Aug;72(8):680-690
pubmed: 28237299
J Oncol Pract. 2013 Jan;9(1):65-7
pubmed: 23633975
AJR Am J Roentgenol. 2013 Jul;201(1):80-96
pubmed: 23789661
J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S377-90
pubmed: 19560026
J Vasc Interv Radiol. 2018 Feb;29(2):268-275.e1
pubmed: 29203394
Hepatology. 2018 Jan;67(1):358-380
pubmed: 28130846
Ann Oncol. 2019 May 1;30(5):871-873
pubmed: 30715202
Radiographics. 2001 Oct;21 Spec No:S17-35; discussion S36-9
pubmed: 11598245
Radiology. 2001 Nov;221(2):447-54
pubmed: 11687689